Results 131 to 140 of about 2,908,134 (284)

Blood RNA Biomarker Signatures for Early Diagnosis and Prognosis in Ischemic and Hemorrhagic Stroke: The IBIS‐CT1 Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau   +11 more
wiley   +1 more source

Deep Learning Pose Estimation for Phenotyping of Co‐Occurring Hyperkinetic Movement Disorders

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore whether routine outpatient video combined with deep learning‐based pose estimation and clinically interpretable kinematic features can support multi‐label phenotyping of co‐occurring hyperkinetic movement disorders (HMDs).
Laura Cif   +17 more
wiley   +1 more source

Advisory Council Seminar IV, 2 July 2013: IDS Rising Powers in International Development Advisory Council Discussion

open access: yes, 2013
This document presents a summary of a discussion held on 2 July 2013 between members of the Advisory Council of the IDS Rising Powers in International Development (RPID) programme and IDS RPID staff members.
IDS Rising Powers in International Development (RPID) Programme (19288516)
core   +1 more source

Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias   +3 more
wiley   +1 more source

IDS Project Workflow Toolkit [PDF]

open access: yes, 2013
Truly effective resource sharing depends upon each library running at peak efficiency. The goal of the Workflow Toolkit is to help ILL staff implement best practices that will save valuable turnaround time, while also cutting the costs of doing business.
IDS Project
core  

Table listing SICAvar gene IDs determined by LC-MS/MS analysis of Pk1(A+), Pk1(B+)1+ parasites.

open access: yes, 2013
Immunoprecipitates were generated with a pan-SICACyto antibody and trophozoite extracts from Pk1(A+), Pk1(B+)1+ protein expression. Gene IDs representing the same gene are similarly color-coded. Subtelomeric genes are in bold.
Yaohui Bai (161177)   +5 more
core   +1 more source

Region Specific miRNA–mRNA Networks in Gray and White Matter Lesions of Progressive Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Multiple sclerosis (MS) is a neurodegenerative demyelinating disease of the central nervous system. This study aimed to identify micro‐RNA (miRNA)–mRNA regulatory networks underlying region‐specific molecular mechanisms in white matter and gray matter lesions in progressive MS.
Adya Sapra   +5 more
wiley   +1 more source

DFID-IDS Learning Event Report, December 2012: Understanding Health, Social Policy and Civil Society in the BRICS Countries

open access: yes, 2013
This document presents a summary of a series of meetings held at the DFID offices in London on 6 December 2012. The meetings, attended by DFID and IDS staff, constituted a learning event that aimed to communicate key IDS findings at this stage of the ...
IDS Rising Powers in International Development (RPID) Programme (19288516)
core   +1 more source

Troponin T and Neurofilament Light Chain Levels as Complementary Biomarkers of Disease Accumulation and Aggressiveness in Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is a clinically heterogeneous neurodegenerative disease requiring reliable biomarkers to improve patient stratification and trial design. While serum neurofilament light chain (sNfL) reflects neuroaxonal stress and disease aggressiveness, troponin T (TnT) may capture complementary aspects of ...
Julia Sellin   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy